Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 4, p. s582, 2025. DOI: 10.25251/gdd40x24. Disponível em: https://skin.dermsquared.com/skin/article/view/3495. Acesso em: 16 nov. 2025.